The Tourniquet test<\/strong> (historically designated as Gilliatt’s test or the pneumatic tourniquet maneuver) is a specialized clinical and neurosensory provocative test designed to evaluate median nerve dysfunction secondary to compression within the carpal tunnel. Developed by Roger William Gilliatt and T. G. Wilson in 1953, the assessment leverages the physiological principle of transient neural ischemia to provoke or exacerbate neuropathic symptoms\u2014specifically sensory disturbances such as paresthesia, dysesthesia, numbness, and burning pain\u2014in the sensory distribution of the median nerve. The operational protocol involves applying a pneumatic blood pressure cuff proximal to the elbow or on the upper arm, inflating it to a suprasystolic pressure (exceeding the patient’s measured systolic blood pressure), and monitoring symptom evolution over a standardized interval of 60 seconds.<\/p>\n Psychometrically and diagnostically, the Tourniquet test functions as an observational binary indicator accompanied by a continuous temporal metric (latency to symptom onset in seconds). Although historically utilized as a primary bedside maneuver alongside Phalen’s test and Tinel’s sign, contemporary diagnostic validity studies demonstrate variable sensitivity ranging from 44% to 87% and specificity between 65% and 90% when evaluated against electrodiagnostic gold standards (electromyography<\/a> and nerve conduction studies). Inter-examiner reliability yields moderate concordance (Cohen’s kappa coefficients typically ranging from 0.52 to 0.74). This article delivers a comprehensive academic analysis of the Tourniquet test, examining its biophysical foundations, theoretical constructs surrounding ischemic axonal hypersensitivity, psychometric performance, factor structure within latent diagnostic models, and clinical utility in assessing carpal tunnel syndrome<\/a>.<\/p>\n Tourniquet test, Gilliatt test, carpal tunnel syndrome, median nerve compression, provocative testing, neurosensory assessment, ischemia-induced paresthesia, sensory threshold, diagnostic validity, nerve conduction<\/p>\n The Tourniquet test was originally conceptualized, operationalized, and introduced into clinical neurology by:<\/p>\n Subsequent methodological standardizations and diagnostic validation studies have been advanced by clinical researchers in orthopedics, physical medicine and rehabilitation, and clinical neurophysiology, including George S. Phalen, Robert M. Szabo, and Joy C. MacDermid.<\/p>\n The fundamental purpose of the Tourniquet test is the systematic provocation and identification of aberrant mechanosensitive and ischemic reactions in chronically compressed peripheral nerves, specifically the median nerve<\/a> traversing the fibro-osseous carpal canal. In healthy peripheral nervous tissue, acute total limb ischemia produced by arterial occlusion typically requires prolonged deprivation\u2014often between 12 to 20 minutes\u2014before distal sensory axons exhibit spontaneous ectopic firing, sensory blunting, or cutaneous paresthesia. However, nerves suffering from chronic, focal mechanical compression exhibit microvascular compromise, altered axolemmal permeability, and chronic endoneurial edema. Under these pathological conditions, acute arterial occlusion rapidly precipitates severe focal metabolic distress, causing hyperexcitable axonal membranes to discharge spontaneously within a minute of ischemic induction.<\/p>\n Clinically, the instrument serves several interconnected purposes across physical medicine, orthopedic hand surgery, occupational health, and neurorehabilitation:<\/p>\n While categorized structurally as a physical and neurosensory diagnostic maneuver, the Tourniquet test evaluates constructs rooted in somatosensory psychophysics, nociceptive processing, and somatoperceptual reporting. The primary construct under measurement is ischemic sensory provocation<\/strong>, which interfaces objective axonal pathophysiology with subjective psychophysical perception. The instrument assesses how altered physical neural states are translated into perceived sensory changes within conscious awareness.<\/p>\n The construct encompasses three primary operational dimensions:<\/p>\n From a psychophysical vantage point, the test demands that the patient continuously attend to internal somatosensory signals while filtering out ambient tactile noise and the mechanical pressure exerted by the blood pressure cuff on the proximal arm. Thus, the assessment inherently integrates the patient’s individual pain threshold, somatic vigilance, cognitive reporting biases, and neurophysiological afferent volley transmission. When chronic pain or central sensitization is present, patients may report generalized, hyperalgesic limb responses that must be disentangled from focal median nerve ischemic paresthesia.<\/p>\n The theoretical architecture underpinning the Tourniquet test rests upon the ischemic-microvascular hypothesis<\/strong> of entrapment neuropathies, initially articulated by Gilliatt and Wilson (1953) and subsequently elaborated through experimental neurobiology by Sydney Sunderland, Jos\u00e9 Ochoa, and Peter J. Dyck. Under baseline physiological conditions, peripheral nerve conduction requires oxidative metabolism to sustain the adenosine triphosphate (ATP)-dependent sodium-potassium exchange pump (Na+\/K+-ATPase<\/a>), maintaining negative resting membrane potential across the axolemma.<\/p>\n Chronic mechanical entrapment within the unyielding carpal tunnel creates a cascade of physiological alterations:<\/p>\n When the pneumatic cuff is inflated above systolic blood pressure, all arterial blood flow to the distal limb is abruptly arrested. In normal axons possessing healthy endoneurial microvascular reserves, intraneural oxygen tension remains sufficient to fuel Na+\/K+-ATPase pumps for a substantial duration before conduction failure or spontaneous depolarization occurs. However, in chronically compromised median nerve segments, oxygen tension plummets almost instantaneously. Deprived of ATP, the resting membrane potential drifts toward depolarization. The aberrantly distributed sodium channels reach activation threshold, initiating high-frequency ectopic bursts that propagate centrally to the primary somatosensory cortex (postcentral gyrus<\/a>), perceived by the individual as rapid-onset paresthesia or acute sensory worsening within 60 seconds.<\/p>\n The diagnostic and construct validity of the Tourniquet test has been investigated across numerous clinical studies comparing physical provocative maneuvers against objective criterion standards, predominantly nerve conduction studies (NCS) assessing sensory nerve action potential (SNAP) amplitudes and distal motor latencies (DML).<\/p>\n Diagnostic accuracy metrics reported in peer-reviewed literature demonstrate consistent trends, summarized in the table below:<\/p>\n2. Keywords<\/h2>\n
3. Authors<\/h2>\n
\n
4. Purpose<\/h2>\n
\n
5. Psychological Construct<\/h2>\n
Dimensions of the Construct<\/h3>\n
\n
Psychophysical Threshold Dynamics<\/h3>\n
6. Theoretical Framework<\/h2>\n
The Microvascular Cascade<\/h3>\n
\n
Acute Ischemic Challenge as an Analytical Mechanism<\/h3>\n
7. Validity<\/h2>\n
Criterion and Diagnostic Validity<\/h3>\n